OrbiMed Capital GP IV LLC's Net Worth
$818 Million
Who is OrbiMed Capital GP IV LLC?
OrbiMed Capital GP IV LLC has an estimated net worth of $818 Million. This is based on reported shares across multiple companies, which include Relypsa Inc, Mirati Therapeutics, Inc., INTERCEPT PHARMACEUTICALS INC, Alector, Inc., ARMO BioSciences, Inc., Acutus Medical, Inc., Principia Biopharma Inc., TELA Bio, Inc., OTONOMY, INC., Arsanis, Inc., Audentes Therapeutics, Inc., and Anthera Pharmaceuticals Inc.
SEC CIK
OrbiMed Capital GP IV LLC's CIK is 0001502240
Past Insider Trading and Trends
2019 was OrbiMed Capital GP IV LLC's most active year for acquiring shares with 19 total transactions. OrbiMed Capital GP IV LLC's most active month to acquire stocks was the month of October. 2015 was OrbiMed Capital GP IV LLC's most active year for disposing of shares, totalling 56 transactions. OrbiMed Capital GP IV LLC's most active month to dispose stocks was the month of February. 2021 saw OrbiMed Capital GP IV LLC paying a total of $14,999,992.00 for 1,071,428 shares, this is the most they've acquired in one year. In 2018 OrbiMed Capital GP IV LLC cashed out on 11,183,160 shares for a total of $226,625,692.36, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Relypsa Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -54.64% | -4.04M |
$32.00 | -$129,388,328.00 | 3.36M |
Jul 22 - Jul 25
| |||
Form 4
| -6.33% | -500.00K |
$27.18 | -$13,588,013.17 | 7.4M |
Dec 21 - Dec 23
| |||
Form 4
| +6.76% | 500K |
$12.56 | $6,280,165.00 | 7.9M |
Oct 22
| |||
Form 4
| -16.46% | -1.46M |
$34.13 | -$49,746,215.63 | 7.4M |
May 18
| |||
Form 4
| -1.05% | -94.00K |
$25.27 | -$2,375,266.00 | 8.86M |
Sep 16 - Sep 17
| |||
Form 4
| -9.96% | -990.00K |
$26.35 | -$26,086,500.00 | 8.95M |
Aug 15
| |||
Form 4
|
∞
| 9.94M |
$7.16 | -$300,102.00 | 9.94M |
Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mirati Therapeutics, Inc. (MRTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.57% | 100K |
$20.00 | $2,000,000.00 | 1.27M |
Feb 3
| |||
Form 4
| -8.42% | -107.33K |
$21.66 | -$2,325,229.14 | 1.17M |
Jun 27 - Jul 1
| |||
Form 4
| +10.88% | 125K |
$17.50 | $2,187,500.00 | 1.27M |
Oct 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INTERCEPT PHARMACEUTICALS INC (ICPT) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.03% | 285 |
—
|
—
| 1.12M |
Jul 17
| |||
Form 4
| -12.31% | -157.20K |
$286.75 | -$45,076,442.00 | 1.12M |
Mar 26
| |||
Form 4
| -13.99% | -207.80K |
$274.41 | -$57,022,705.96 | 1.28M |
Mar 23 - Mar 25
| |||
Form 4
| -6.97% | -111.26K |
$298.06 | -$33,161,087.38 | 1.49M |
Aug 25 - Aug 26
| |||
Form 4
| -3.62% | -60.00K |
$299.82 | -$17,989,206.87 | 1.6M |
Aug 14
| |||
Form 4
| +0.02% | 324 |
—
|
—
| 1.66M |
Aug 9
| |||
Form 4
| +0.10% | 1.66K |
—
|
—
| 1.66M |
May 7 - May 9
| |||
Form 4
| -4.68% | -81.31K |
$320.00 | -$26,017,600.00 | 1.65M |
Apr 9
| |||
Form 4
| +0.02% | 324 |
—
|
—
| 1.74M |
Feb 9
| |||
Form 4
| +0.02% | 325 |
—
|
—
| 1.74M |
Nov 9
| |||
Form 4
| -2.26% | -40.09K |
$62.50 | -$2,505,500.00 | 1.74M |
Oct 21
| |||
Form 4
| -17.50% | -376.58K |
$62.50 | -$23,536,562.50 | 1.78M |
Oct 15
| |||
Form 4
| +0.02% | 325 |
—
|
—
| 2.15M |
Aug 9
| |||
Form 4
| +0.02% | 324 |
—
|
—
| 2.15M |
May 9
| |||
Form 4
| +0.03% | 649 |
—
|
—
| 2.15M |
Apr 9
| |||
Form 4
|
∞
| 2.15M |
$15.00 |
—
| 2.15M |
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Alector, Inc. (ALEC) Snapshot price: $6.425
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.54% | -85.41K |
$23.53 | -$2,009,559.11 | 15.79M |
Apr 14 - Apr 16
| |||
Form 4
| -1.53% | -379.88K |
$23.51 | -$9,019,570.89 | 24.5M |
Apr 7 - Apr 9
| |||
Form 4
| -2.91% | -250.00K |
$24.50 | -$6,125,000.00 | 8.33M |
Mar 31
| |||
Form 4
| -0.53% | -138.65K |
$25.05 | -$3,425,268.96 | 25.91M |
Mar 23 - Mar 25
| |||
Form 4
| -17.70% | -1.87M |
$26.00 | -$48,729,278.00 | 8.72M |
Mar 2
| |||
Form 4
| -3.46% | -380.00K |
$19.50 | -$7,409,941.50 | 10.59M |
Jan 9
| |||
Form 4
| -1.16% | -519.38K |
$19.42 | -$10,209,720.70 | 44.15M |
Dec 20 - Dec 26
| |||
Form 4
| -7.67% | -954.10K |
$18.52 | -$17,669,932.00 | 11.49M |
Dec 17
| |||
Form 4
| -5.04% | -650.00K |
$17.90 | -$11,635,000.00 | 12.24M |
Aug 7
| |||
Form 4
|
∞
| 13.09M |
$19.00 | $3,860,800.00 | 13.09M |
Feb 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARMO BioSciences, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -50.00% | -4.12M |
$50.00 | -$205,945,150.00 | 4.12M |
Jun 22
| |||
Form 4
|
∞
| 4.12M |
—
|
—
| 4.12M |
Jan 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||